NVS
Income statement / Annual
Last year (2024), Novartis AG's total revenue was $51.72 B,
an increase of 10.85% from the previous year.
In 2024, Novartis AG's net income was $11.94 B.
See Novartis AG,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$51.72 B |
$46.66 B |
$43.46 B |
$43.97 B |
$49.90 B |
$48.68 B |
$46.10 B |
$43.40 B |
$49.44 B |
$50.39 B |
| Cost of Revenue |
$12.83 B
|
$12.47 B
|
$11.58 B
|
$11.74 B
|
$15.12 B
|
$14.43 B
|
$14.51 B
|
$13.63 B
|
$17.52 B
|
$17.40 B
|
| Gross Profit |
$38.90 B
|
$34.19 B
|
$31.88 B
|
$32.24 B
|
$34.78 B
|
$34.25 B
|
$31.59 B
|
$29.77 B
|
$31.92 B
|
$32.98 B
|
| Gross Profit Ratio |
0.75
|
0.73
|
0.73
|
0.73
|
0.7
|
0.7
|
0.69
|
0.69
|
0.65
|
0.65
|
| Research and Development Expenses |
$10.02 B
|
$11.37 B
|
$9.17 B
|
$8.64 B
|
$8.98 B
|
$9.40 B
|
$8.49 B
|
$8.39 B
|
$9.04 B
|
$8.94 B
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.14 B
|
$2.19 B
|
$2.48 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$12.86 B
|
$12.00 B
|
$11.77 B
|
| Selling, General & Administrative Expenses |
$12.57 B
|
$12.52 B
|
$12.19 B
|
$12.83 B
|
$14.20 B
|
$14.37 B
|
$13.72 B
|
$12.47 B
|
$14.19 B
|
$14.25 B
|
| Other Expenses |
$1.76 B
|
$531.00 M
|
$2.57 B
|
$715.00 M
|
$1.45 B
|
$1.40 B
|
$980.00 M
|
$215.00 M
|
$417.00 M
|
$824.00 M
|
| Operating Expenses |
$24.35 B
|
$24.42 B
|
$23.93 B
|
$22.18 B
|
$24.63 B
|
$25.17 B
|
$23.19 B
|
$21.07 B
|
$23.65 B
|
$24.01 B
|
| Cost And Expenses |
$37.18 B
|
$36.89 B
|
$35.52 B
|
$33.92 B
|
$39.75 B
|
$39.59 B
|
$37.70 B
|
$34.70 B
|
$41.17 B
|
$41.41 B
|
| Interest Income |
$567.68 M
|
$629.24 M
|
$377.74 M
|
$71.00 M
|
$91.00 M
|
$245.25 M
|
$292.67 M
|
$110.00 M
|
$43.00 M
|
$32.98 M
|
| Interest Expense |
$1.04 B
|
$876.12 M
|
$834.62 M
|
$905.00 M
|
$921.00 M
|
$902.93 M
|
$973.22 M
|
$802.00 M
|
$729.00 M
|
$691.47 M
|
| Depreciation & Amortization |
$6.07 B
|
$8.28 B
|
$6.71 B
|
$5.60 B
|
$6.46 B
|
$5.83 B
|
$5.21 B
|
$4.74 B
|
$6.04 B
|
$5.47 B
|
| EBITDA |
$20.72 B |
$18.26 B |
$14.68 B |
$30.91 B |
$17.21 B |
$15.62 B |
$20.24 B |
$14.59 B |
$14.57 B |
$14.26 B |
| EBITDA Ratio |
0.4
|
0.39
|
0.34
|
0.7
|
0.34
|
0.32
|
0.44
|
0.34
|
0.29
|
0.28
|
| Operating Income Ratio |
0.28
|
0.21
|
0.18
|
0.23
|
0.2
|
0.19
|
0.18
|
0.2
|
0.17
|
0.18
|
| Total Other Income/Expenses Net |
-$904.00 M
|
-$646.00 M
|
-$769.00 M
|
$14.47 B
|
-$274.00 M
|
-$146.00 M
|
$5.69 B
|
$400.00 M
|
-$451.00 M
|
-$843.00 M
|
| Income Before Tax |
$13.64 B
|
$9.12 B
|
$7.18 B
|
$24.53 B
|
$9.88 B
|
$8.94 B
|
$14.10 B
|
$9.10 B
|
$7.82 B
|
$8.13 B
|
| Income Before Tax Ratio |
0.26
|
0.2
|
0.17
|
0.56
|
0.2
|
0.18
|
0.31
|
0.21
|
0.16
|
0.16
|
| Income Tax Expense |
$1.70 B
|
$551.00 M
|
$1.13 B
|
$1.63 B
|
$1.81 B
|
$1.79 B
|
$1.30 B
|
$1.60 B
|
$1.12 B
|
$1.11 B
|
| Net Income |
$11.94 B
|
$14.85 B
|
$6.96 B
|
$24.02 B
|
$8.07 B
|
$11.73 B
|
$12.61 B
|
$7.70 B
|
$6.71 B
|
$17.78 B
|
| Net Income Ratio |
0.23
|
0.32
|
0.16
|
0.55
|
0.16
|
0.24
|
0.27
|
0.18
|
0.14
|
0.35
|
| EPS |
5.92 |
7.15 |
3.19 |
10.71 |
3.54 |
3.12 |
5.44 |
3.28 |
2.82 |
7.4 |
| EPS Diluted |
5.87 |
7.1 |
3.17 |
10.63 |
3.52 |
3.08 |
5.38 |
3.25 |
2.8 |
7.29 |
| Weighted Average Shares Out |
$2.02 B
|
$2.08 B
|
$2.18 B
|
$2.24 B
|
$2.28 B
|
$2.29 B
|
$2.32 B
|
$2.35 B
|
$2.38 B
|
$2.40 B
|
| Weighted Average Shares Out Diluted |
$2.04 B
|
$2.09 B
|
$2.20 B
|
$2.26 B
|
$2.30 B
|
$2.32 B
|
$2.34 B
|
$2.37 B
|
$2.40 B
|
$2.44 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
